DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹1,755 Cr | ₹1,539 Cr | ₹2,454 Cr | ₹1,728 Cr | ₹1,821 Cr |
What is the latest Total Current Liabilities ratio of DIVIS LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹1,755 Cr |
Mar2023 | ₹1,539 Cr |
Mar2022 | ₹2,454 Cr |
Mar2021 | ₹1,728 Cr |
Mar2020 | ₹1,821 Cr |
How is Total Current Liabilities of DIVIS LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1,755 Cr | 14.04 | |
Mar2023 | ₹1,539 Cr | -37.30 | |
Mar2022 | ₹2,454 Cr | 42.01 | |
Mar2021 | ₹1,728 Cr | -5.06 | |
Mar2020 | ₹1,821 Cr | - |
Compare Total Current Liabilities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹151,439.9 Cr | -2.3% | 2.3% | 57.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,395.0 Cr | -3.6% | -8.2% | 5.5% | Stock Analytics | |
CIPLA | ₹119,252.0 Cr | -0.4% | 5.8% | 1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹101,889.0 Cr | -1.2% | -9.8% | 16.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,191.9 Cr | -2.8% | -2.7% | -9.5% | Stock Analytics | |
MANKIND PHARMA | ₹94,909.6 Cr | -3.6% | -6.5% | 6.4% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.3% |
2.3% |
57.6% |
SENSEX | -2% |
-2.3% |
2.5% |
You may also like the below Video Courses